Cerebrovascular Complications in Patients with Cancer

ABSTRACT

Stroke in the cancer patient is often caused by disorders of coagulation that are induced by the cancer, by cancer metastatic to the central nervous system, or by coagulation disorders or vascular injury due to cancer therapy. Nonbacterial thrombotic endocarditis in association with diffuse thrombosis of cerebral vessels is often the cause of cerebral infarction. Venous occlusion is most common in leukemic patients, but can also result from growth of solid tumor in the adjacent skull or dura. Chemotherapy administration is associated with a small risk of cerebral arterial or venous thrombosis. Radiation that is administered to the neck can result in delayed carotid atherosclerosis. Tumor embolization to the brain is a rare cause of stroke. Fungal septic cerebral emboli occur most commonly in leukemic patients who have undergone bone marrow transplantation. Hemorrhages occur in the brain parenchyma or the subdural and subarachnoid spaces and are most commonly caused by acute disseminated intravascular coagulation or metastatic tumor. Hemolysis from chemotherapy administration is a rare cause of brain hemorrhage. Careful clinical assessment, neuroimaging studies, measurement of coagulation function, and echocardiography are the most useful modalities to identify the cause of stroke.

KEYWORDS

Coagulopathy - nonbacterial thrombotic endocarditis - disseminated intravascular coagulation - venous occlusion

REFERENCES

• 1 Lee A Y. Cancer and thromboembolic disease: pathogenic mechanisms.  Cancer Treat Rev. 2002;  28(3) 137-140
• 2 Zhang Y-Y, Chan D KY, Cordato D, Shen Q, Sheng A Z. Stroke risk factor, pattern and outcome in patients with cancer.  Acta Neurol Scand. 2006;  114(6) 378-383
• 3 Cestari D M, Weine D M, Panageas K S, Segal A Z, DeAngelis L M. Stroke in patients with cancer: incidence and etiology.  Neurology. 2004;  62(11) 2025-2030
• 4 Graus F, Rogers L R, Posner J B. Cerebrovascular complications in patients with cancer.  Medicine (Baltimore). 1985;  64(1) 16-35
• 5 Kim S G, Hong J M, Kim H Y et al.. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea.  Stroke. 2010;  41(4) 798-801
• 6 Rogers L R, Cho E-S, Kempin S, Posner J B. Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation.  Am J Med. 1987;  83(4) 746-756
• 7 Reisner S A, Brenner B, Haim N, Edoute Y, Markiewicz W. Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical entity.  J Am Soc Echocardiogr. 2000;  13(9) 876-881
• 8 Reagan T J, Okazaki H. The thrombotic syndrome associated with carcinoma. A clinical and neuropathologic study.  Arch Neurol. 1974;  31(6) 390-395
• 9 Collins R C, Al-Mondhiry H, Chernik N L, Posner J B. Neurologic manifestations of intravascular coagulation in patients with cancer. A clinicopathologic analysis of 12 cases.  Neurology. 1975;  25(9) 795-806
• 10 Raizer J J, DeAngelis L M. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients.  Neurology. 2000;  54(6) 1222-1226
• 11 Edoute Y, Haim N, Rinkevich D, Brenner B, Reisner S A. Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients.  Am J Med. 1997;  102(3) 252-258
• 12 Patchell R A, White III C L, Clark A W, Beschorner W E, Santos G W. Nonbacterial thrombotic endocarditis in bone marrow transplant patients.  Cancer. 1985;  55(3) 631-635
• 13 Santoro N, Giordano P, Del Vecchio G C et al.. Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study.  J Pediatr Hematol Oncol. 2005;  27(3) 153-157
• 14 Masjuan J, Pardo J, Callejo J M, Andrés M T, Alvarez-Cermeño J C. Tamoxifen: a new risk factor for cerebral sinus thrombosis.  Neurology. 2004;  62(2) 334-335
• 15 Singhal A B, Topcuoglu M A, Buonanno F S. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study.  Stroke. 2002;  33(5) 1267-1273
• 16 Lee A Y, Levine M N, Baker R I Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.  N Engl J Med. 2003;  349(2) 146-153
• 17 de Bruijn S F, Budde M, Teunisse S, de Haan R J, Stam J. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis.  Neurology. 2000;  54(8) 1687-1689
• 18 Soleau S W, Schmidt R, Stevens S, Osborn A, MacDonald J D. Extensive experience with dural sinus thrombosis.  Neurosurgery. 2003;  52(3) 534-544 discussion 542-544
• 19 Klein P, Haley E C, Wooten G F, VandenBerg S R. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases.  Arch Neurol. 1989;  46(10) 1149-1152
• 20 Anghel G, Petrinato G, Severino A et al.. Intravascular B-cell lymphoma: report of two cases with different clinical presentation but rapid central nervous system involvement.  Leuk Lymphoma. 2003;  44(8) 1353-1359
• 21 Herman C, Kupsky W J, Rogers L, Duman R, Moore P. Leptomeningeal dissemination of malignant glioma simulating cerebral vasculitis. Case report with angiographic and pathological studies.  Stroke. 1995;  26(12) 2366-2370
• 22 Williams R L, Meltzer C C, Smirniotopoulos J G, Fukui M B, Inman M. Cerebral MR imaging in intravascular lymphomatosis.  AJNR Am J Neuroradiol. 1998;  19(3) 427-431
• 23 Matsumoto K, Ohta M, Takeshita I. Reversible non-thrombotic occlusion of the superior sagittal sinus caused by metastatic malignant lymphoma—case report.  Neurol Med Chir (Tokyo). 2003;  43(7) 349-351
• 24 Ponzoni M, Ferreri A JM, Campo E et al.. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.  J Clin Oncol. 2007;  25(21) 3168-3173
• 25 Lee A Y, Levine M N. The thrombophilic state induced by therapeutic agents in the cancer patient.  Semin Thromb Hemost. 1999;  25(2) 137-145
• 26 Gugliotta L, Mazzucconi M G, Leone G The GIMEMA Group et al. Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study.  Eur J Haematol. 1992;  49(2) 63-66
• 27 Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Böhles H. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.  J Pediatr Hematol Oncol. 2003;  25(6) 484-487
• 28 Steele S R, Martin M J, Mullenix P S, Crawford J V, Cuadrado D S, Andersen C A. Focused high-risk population screening for carotid arterial stenosis after radiation therapy for head and neck cancer.  Am J Surg. 2004;  187(5) 594-598
• 29 Li S H, Chen W H, Tang Y et al.. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients.  Clin Neurol Neurosurg. 2006;  108(2) 150-156
• 30 Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C. Increased incidence of stroke in women with breast cancer.  Eur J Cancer. 2005;  41(3) 423-429
• 31 Pritchard K I, Paterson A H, Paul N A, Zee B, Fine S, Pater J. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  J Clin Oncol. 1996;  14(10) 2731-2737
• 32 Bushnell C D, Goldstein L B. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis.  Neurology. 2004;  63(7) 1230-1233
• 33 Geiger A M, Fischberg G M, Chen W, Bernstein L. Stroke risk and tamoxifen therapy for breast cancer.  J Natl Cancer Inst. 2004;  96(20) 1528-1536
• 34 Cuzick J, Forbes J F, Sestak I International Breast Cancer Intervention Study I Investigators et al. Long-term results of tamoxifen prophylaxis for breast cancer—96-month follow-up of the randomized IBIS-I trial.  J Natl Cancer Inst. 2007;  99(4) 272-282
• 35 Bowers D C, McNeil D E, Liu Y et al.. Stroke as a late treatment effect of Hodgkin's disease: a report from the Childhood Cancer Survivor Study.  J Clin Oncol. 2005;  23(27) 6508-6515
• 36 De Bruin M L, Dorresteijn L D, van't Veer M B et al.. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.  J Natl Cancer Inst. 2009;  101(13) 928-937
• 37 Kikuchi A, Maeda M, Hanada R Tokyo Children's Cancer Study Group (TCCSG) et al. Moyamoya syndrome following childhood acute lymphoblastic leukemia.  Pediatr Blood Cancer. 2007;  48(3) 268-272
• 38 Ito Y, Arahata Y, Goto Y et al.. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.  AJNR Am J Neuroradiol. 1998;  19(3) 415-417
• 39 Marcel M, Leys D, Mounier-Vehier F et al.. Clinical outcome in patients with high-grade internal carotid artery stenosis after irradiation.  Neurology. 2005;  65(6) 959-961
• 40 Cheng S WK, Wu L LH, Ting A CW, Lau H, Lam L K, Wei W I. Irradiation-induced extracranial carotid stenosis in patients with head and neck malignancies.  Am J Surg. 1999;  178(4) 323-328
• 41 Kashyap V S, Moore W S, Quinones-Baldrich W J, Baldrich W J. Carotid artery repair for radiation-associated atherosclerosis is a safe and durable procedure.  J Vasc Surg. 1999;  29(1) 90-96 discussion 97-99
• 42 Lesèche G, Castier Y, Chataigner O et al.. Carotid artery revascularization through a radiated field.  J Vasc Surg. 2003;  38(2) 244-250
• 43 O'Neill B P, Dinapoli R P, Okazaki H. Cerebral infarction as a result of tumor emboli.  Cancer. 1987;  60(1) 90-95
• 44 Lefkovitz N W, Roessmann U, Kori S H. Major cerebral infarction from tumor embolus.  Stroke. 1986;  17(3) 555-557
• 45 Murata J, Sawamura Y, Takahashi A, Abe H, Saitoh H. Intracerebral hemorrhage caused by a neoplastic aneurysm from small-cell lung carcinoma: case report.  Neurosurgery. 1993;  32(1) 124-126
• 46 Pickering L, Cox I, Pandha H. Left atrial sarcoma presenting as cerebral infarction.  Lancet Oncol. 2001;  2(11) 705-706
• 47 Urrutia V, Jichici D, Thomas C E, Nunes L W, Schwartzman R J. Embolic stroke secondary to an aortic arch tumor—a case report.  Angiology. 2000;  51(11) 959-962
• 48 Brown D V, Faber L P, Tuman K J. Perioperative stroke caused by arterial tumor embolism.  Anesth Analg. 2004;  98(3) 806-809
• 49 Coplin W M, Cochran M S, Levine S R, Crawford S W. Stroke after bone marrow transplantation: frequency, aetiology and outcome.  Brain. 2001;  124(Pt 5) 1043-1051
• 50 Kawanami T, Kurita K, Yamakawa M, Omoto E, Kato T. Cerebrovascular disease in acute leukemia: a clinicopathological study of 14 patients.  Intern Med. 2002;  41(12) 1130-1134
• 51 Walsh T J, Hier D B, Caplan L R. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.  Ann Neurol. 1985;  18(5) 574-582
• 52 Gabelmann A, Klein S, Kern W et al.. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients.  Eur J Neurol. 2007;  14 548-555
• 53 Navi B B, Reichman J S, Berlin D et al.. Intracerebral and subarachnoid hemorrhage in patients with cancer.  Neurology. 2010;  74(6) 494-501
• 54 Antman K H, Skarin A T, Mayer R J, Hargreaves H K, Canellos G P. Microangiopathic hemolytic anemia and cancer: a review.  Medicine (Baltimore). 1979;  58(5) 377-384
• 55 Gordon L I, Kwaan H C. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient.  Semin Thromb Hemost. 1999;  25(2) 217-221
• 56 Humphreys B D, Sharman J P, Henderson J M et al.. Gemcitabine-associated thrombotic microangiopathy.  Cancer. 2004;  100(12) 2664-2670
• 57 Graus F, Saiz A, Sierra J et al.. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study.  Neurology. 1996;  46(4) 1004-1009
• 58 Najima Y, Ohashi K, Miyazawa M et al.. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.  Am J Hematol. 2009;  84(5) 298-301
• 59 Pitner S E, Johnson W W. Chronic subdural hematoma in childhood acute leukemia.  Cancer. 1973;  32(1) 185-190
• 60 Jourdan E, Dombret H, Glaisner S, Micléa J M, Castaigne S, Degos L. Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component.  Br J Haematol. 1995;  89(3) 527-530
• 61 Lengfelder E, Saussele S, Weisser A, Büchner T, Hehlmann R. Treatment concepts of acute promyelocytic leukemia.  Crit Rev Oncol Hematol. 2005;  56(2) 261-274
• 62 Colosimo M, McCarthy N, Jayasinghe R, Morton J, Taylor K, Durrant S. Diagnosis and management of subdural haematoma complicating bone marrow transplantation.  Bone Marrow Transplant. 2000;  25(5) 549-552
• 63 Lieu A S, Hwang S L, Howng S L, Chai C Y. Brain tumors with hemorrhage.  J Formos Med Assoc. 1999;  98(5) 365-367
• 64 Minette S E, Kimmel D W. Subdural hematoma in patients with systemic cancer.  Mayo Clin Proc. 1989;  64(6) 637-642
• 65 McIver J I, Scheithauer B W, Rydberg C H, Atkinson J LD. Metastatic hepatocellular carcinoma presenting as epidural hematoma: case report.  Neurosurgery. 2001;  49(2) 447-449
• 66 Würthner J U, Köhler G, Behringer D, Lindemann A, Mertelsmann R, Lübbert M. Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis: a clinicopathologic report of four cases.  Cancer. 1999;  85(2) 368-374
• 67 Nowacki P, Fryze C, Zdziarska B, Zyluk B, Grzelec H, Dudzik T. Central nervous system leukostasis in patients with leukemias and lymphomas.  Folia Neuropathol. 1995;  33(1) 59-65
• 68 McKenzie C R, Rengachary S S, McGregor D H, Dixon A Y, Suskind D L. Subdural hematoma associated with metastatic neoplasms.  Neurosurgery. 1990;  27(4) 619-624 discussion 624-625
• 69 Bromberg J E, Vandertop W P, Jansen G H. Recurrent subdural haematoma as the primary and sole manifestation of chronic lymphocytic leukaemia.  Br J Neurosurg. 1998;  12(4) 373-376
• 70 Atlas S W, Grossman R I, Gomori J M et al.. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging.  Radiology. 1987;  164(1) 71-77
• 71 Bug G, Anargyrou K, Tonn T et al.. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.  Transfusion. 2007;  47(10) 1843-1850
• 72 Chang M C, Chen T Y, Tang J L et al.. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage.  Am J Hematol. 2007;  82(11) 976-980